In the United States there was an observed increase in prostate cancer mortality from the initiation of PSA based prostate screening, which is likely caused by the labelling of prostate cancer diagnosis to death certificates for older men population as opposed to true increases. This evidence concerns the gene KLK3 and Familial prostate cancer.